GlucoTrack, Inc. (GCTK)
NASDAQ: GCTK · Real-Time Price · USD
0.0949
-0.0110 (-10.39%)
At close: Jun 13, 2025, 4:00 PM
0.0929
-0.0020 (-2.11%)
After-hours: Jun 13, 2025, 7:48 PM EDT
GlucoTrack Employees
GlucoTrack had 11 employees as of December 31, 2024. The number of employees increased by 5 or 83.33% compared to the previous year.
Employees
11
Change (1Y)
5
Growth (1Y)
83.33%
Revenue / Employee
n/a
Profits / Employee
-$2,409,364
Market Cap
2.72M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
GCTK News
- 1 day ago - Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements - GlobeNewsWire
- 9 days ago - Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions - GlobeNewsWire
- 16 days ago - Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD - GlobeNewsWire
- 24 days ago - Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development - GlobeNewsWire
- 4 weeks ago - Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 4 weeks ago - Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor - GlobeNewsWire
- 2 months ago - Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas - GlobeNewsWire
- 2 months ago - Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor - GlobeNewsWire